DiaMedica Therapeutics Ownership | Who Owns DiaMedica Therapeutics?


OverviewForecastFinancialsChartTranscripts

DiaMedica Therapeutics Ownership Summary


DiaMedica Therapeutics is owned by 2.17% institutional investors, 28.34% insiders, and 69.49% retail investors. Cooperman leon g is the largest institutional shareholder, holding 7.61% of DMAC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.74% of its assets in DiaMedica Therapeutics shares.

DMAC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDiaMedica Therapeutics2.17%28.34%69.49%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cooperman leon g3.27M7.61%$17.64M
Blackrock funding, inc. /de1.90M3.83%$15.13M
Paragon associates & paragon associates ii joint venture875.00K1.76%$6.96M
Geode capital management764.25K1.54%$6.08M
Vanguard group723.12K1.46%$5.76M
First manhattan co. llc.505.00K1.18%$3.47M
State street476.58K1.11%$3.27M
Morgan stanley547.61K1.10%$4.36M
Bleichroeder lp382.32K0.89%$2.63M
Susquehanna group, llp374.85K0.88%$2.04M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Paragon associates & paragon associates ii joint venture875.00K14.39%$6.96M
Cooperman leon g3.27M0.55%$17.64M
Members wealth101.38K0.54%$864.28K
Bleichroeder lp382.32K0.51%$2.63M
Eam investors91.42K0.08%$727.74K
Catalyst financial partners38.46K0.03%$306.12K
Private capital management50.00K0.03%$343.50K
Axq capital, lp12.07K0.02%$96.08K
Magnolia capital advisors10.00K0.02%$68.70K
Meridian wealth management50.64K0.01%$403.10K

Top Buyers

HolderShares% AssetsChange
Cooperman leon g3.27M0.55%1.62M
Susquehanna group, llp374.85K0.00%273.39K
State street476.58K0.00%224.63K
Blackrock funding, inc. /de1.90M0.00%222.76K
Ci private wealth140.00K0.00%140.00K

Top Sellers

HolderShares% AssetsChange
Corient ia---132.50K
Aristides capital---106.33K
First manhattan co. llc.505.00K0.01%-101.44K
683 capital management---76.12K
Jane street group---57.55K

New Positions

HolderShares% AssetsChangeValue
Ci private wealth140.00K0.00%140.00K$961.80K
Members wealth101.38K0.54%101.38K$864.28K
Cantor fitzgerald, l. p.100.00K0.01%100.00K$687.00K
Eam investors91.42K0.08%91.42K$727.74K
Sei investments55.66K0.00%55.66K$443.05K

Sold Out

HolderChange
Srs capital advisors-32.00
Federation des caisses desjardins du quebec-230.00
Tortoise investment management-500.00
Point72 (difc)-642.00
Legend financial advisors-1.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202522-72.50%1,075,644-91.57%20.25%11-80.00%5-54.55%
Sep 30, 202519-65.45%1,067,231-87.45%20.63%10-73.68%4-
Jun 30, 202557-5.00%8,620,53214.72%206.52%3911.43%5-50.00%
Mar 31, 20256027.66%7,514,09211.67%177.08%3525.00%10100.00%
Dec 31, 20244711.90%6,729,01220.58%159.24%2827.27%5-16.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF747.20K1.74%-
Vanguard Total Stock Mkt Idx Inv839.16K1.63%-18.51K
iShares Russell 2000 ETF810.96K1.56%810.96K
Fidelity Small Cap Index323.12K0.62%7.35K
Vanguard Institutional Extnd Mkt Idx Tr322.87K0.62%-
iShares Russell 2000 Growth ETF282.46K0.54%282.46K
State St Russell Sm/Mid Cp® Indx SL Cl I191.80K0.37%-
Fidelity Extended Market Index163.53K0.31%2.51K
Vanguard Russell 2000 ETF161.44K0.31%-5.76K
IMC US Ultra Micro Cap111.32K0.21%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 21, 2025STAHLBERG JAN-Buy$1.55M
Nov 20, 2025STAHLBERG JAN-Buy$951.21K
Nov 25, 2025STAHLBERG JAN-Buy$626.82K
Nov 24, 2025STAHLBERG JAN-Buy$317.72K
Nov 19, 2025STAHLBERG JAN-Buy$1.73M

Insider Transactions Trends


DateBuySell
2025 Q33-
2025 Q2--
2025 Q1--
2024 Q22-
2024 Q1--

DMAC Ownership FAQ


Who Owns DiaMedica Therapeutics?

DiaMedica Therapeutics shareholders are primarily institutional investors at 2.17%, followed by 28.34% insiders and 69.49% retail investors. The average institutional ownership in DiaMedica Therapeutics's industry, Biotech Stocks , is 381.47%, which DiaMedica Therapeutics falls below.

Who owns the most shares of DiaMedica Therapeutics?

DiaMedica Therapeutics’s largest shareholders are Cooperman leon g (3.27M shares, 7.61%), Blackrock funding, inc. /de (1.9M shares, 3.83%), and Paragon associates & paragon associates ii joint venture (875K shares, 1.76%). Together, they hold 13.20% of DiaMedica Therapeutics’s total shares outstanding.

Does Blackrock own DiaMedica Therapeutics?

BlackRock is not among the top 10 institutional shareholders of DiaMedica Therapeutics.

Who is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested?

Paragon associates & paragon associates ii joint venture is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested, with 14.39% of its assets in 875K DiaMedica Therapeutics shares, valued at 6.96M$.

Who is the top mutual fund holder of DiaMedica Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of DiaMedica Therapeutics shares, with 1.74% of its total shares outstanding invested in 747.2K DiaMedica Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools